We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

By HospiMedica International staff writers
Posted on 01 Jun 2026

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6. More...

7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients leave the hospital, and invasive catheterization is performed in only a small fraction of cases. Noninvasive options are typically limited to in-hospital imaging or implantables reserved for the highest-risk patients. A new AI-based platform now offers catheterization-comparable hemodynamic assessment using consumer wearables under physician supervision to extend monitoring beyond the hospital.

Coredio’s (Santa Clara, CA, USA) Cardiac Performance Simulation Engine (CPSE) is a software-as-a-medical-device platform (SaMD) dedicated to heart failure hemodynamic assessment. The software-only, device-agnostic system is designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision. CPSE is intended to support clinician assessment by bringing advanced hemodynamic evaluation to where patients spend most of their time.

The platform pairs a physics-based digital twin of the patient’s cardiovascular system with machine-learning models trained on clinical data. After an initial personalization step, patients collect signals via a smartwatch and blood pressure cuff to generate an on-demand indication of hemodynamic status for clinician review. CPSE’s proprietary algorithms are designed to identify abnormal status across four key parameters central to cardiology decision-making: left ventricular end-diastolic pressure, central venous pressure, systemic vascular resistance, and cardiac index.

Coredio reported that the U.S. Food and Drug Administration (FDA) has granted CPSE Breakthrough Device Designation and accepted the platform into the agency’s Total Product Life Cycle Advisory Program (TAP). The company noted it is on an accelerated, priority path toward a future 510(k) submission. By leveraging consumer wearables patients already own, CPSE is designed to help close the gap between hospital-based measurements and outpatient insight. The approach aims to provide a more holistic view of left- and right-sided heart failure status without invasive procedures or additional clinic visits.

“Heart failure management has long been limited by the gap between what we can measure in the hospital and what we can reliably understand once patients return home. Coredio’s approach, using wearable-derived signals and physics-informed AI to estimate hemodynamic status noninvasively, has the potential to give clinicians a more holistic view of patient cardiac function and enable earlier intervention,” said Dr. Jagmeet P. Singh, MD, PhD, Mass General Brigham.

“Heart failure management has long been limited by the gap between what we can assess invasively or with imaging tools and what we can see at home. Coredio’s approach, extracting catheterization-comparable hemodynamic data from consumer wearables using physics-based AI, has the potential to close that gap and give clinicians the visibility they need to intervene earlier and make more informed decisions for heart failure patients,” said Dr. Jennifer Monti, Cardiologist, SSM Health.

Related Links
Coredio


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Fetal Monitor
BT-380
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.